UTHR250117P500000
- 0.00
- 0.000.00%
United Therapeutics Newsroom
United Therapeutics Corporation (UTHR): Among the Cheap Healthcare Stocks to Buy Heading Into 2025
United Therapeutics(UTHR.US) Officer Sells US$3.62 Million in Common Stock
Here Are Updates on United Therapeutics Corp. (UTHR)
United Therapeutics(UTHR.US) Director Sells US$9.78 Million in Common Stock
Express News | Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 9.78 Million in Common Stocks
United Therapeutics(UTHR.US) Officer Sells US$3.7 Million in Common Stock
United Therapeutics Announces Successful World's First UKidney Transplant
Express News | Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 14.47 Million in Common Stocks
$1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today
United Therapeutics(UTHR.US) Officer Sells US$3.68 Million in Common Stock
United Therapeutics (NASDAQ:UTHR) Has A Rock Solid Balance Sheet
United Therapeutics(UTHR.US) Officer Sells US$3.71 Million in Common Stock
The 3.8% Return This Week Takes United Therapeutics' (NASDAQ:UTHR) Shareholders Five-year Gains to 314%
Insider Sale: PRESIDENT AND COO of $UTHR (UTHR) Sells 100 Shares
United Therapeutics(UTHR.US) Officer Sells US$3.73 Million in Common Stock
How Is The Market Feeling About United Therapeutics?
United Therapeutics Insider Sold Shares Worth $2,828,672, According to a Recent SEC Filing
United Therapeutics(UTHR.US) Officer Sells US$3.59 Million in Common Stock
Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 14.53 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 18, $United Therapeutics(UTHR.US)$ Officer Michael Benkowitz intends to sell 40,000 shares of its common stock on Nov 18, with a total market value of approximately $14.53
Earnings Working Against United Therapeutics Corporation's (NASDAQ:UTHR) Share Price